CFO4Life’s Nuveen Dow 30SM Dynamic Overwrite Fund DIAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-31,166
Closed -$448K 90
2015
Q4
$448K Buy
31,166
+1,107
+4% +$15.8K 0.43% 41
2015
Q3
$405K Sell
30,059
-22,658
-43% -$325K 0.43% 39
2015
Q2
$783K Buy
52,717
+738
+1% +$11.2K 0.65% 31
2015
Q1
$789K Sell
51,979
-6,324
-11% -$97.6K 0.66% 33
2014
Q4
$899K Buy
+58,303
New +$939K 0.74% 23

Other funds holding DIAX

CFO4Life's DIAX Position: Q1 2016 in Review

CFO4Life sold out of Nuveen Dow 30SM Dynamic Overwrite Fund (DIAX) in Q1 2016, closing a stake of 31,166 shares — an estimated $448K sold.

CFO4Life first reported a position in DIAX in Q4 2014 and held it in 5 quarters. The position peaked at $899K in Q4 2014. 54 funds tracked by Wall St. Rank hold DIAX as of Q1 2016.

  • CFO4Life reported no remaining Nuveen Dow 30SM Dynamic Overwrite Fund position as of Q1 2016 after selling out during the quarter.
  • CFO4Life sold 31,166 Nuveen Dow 30SM Dynamic Overwrite Fund shares in Q1 2016, an estimated $448K.
  • CFO4Life first reported a position in Nuveen Dow 30SM Dynamic Overwrite Fund in Q4 2014 and held it in 5 quarters.
  • CFO4Life's Nuveen Dow 30SM Dynamic Overwrite Fund position peaked at $899K in Q4 2014.
  • 54 funds tracked by Wall St. Rank held Nuveen Dow 30SM Dynamic Overwrite Fund as of Q1 2016.

Based on CFO4Life's 13F filing for Q1 2016, filed 13 May 2016.